Uganda, in partnership with the WHO and other health organisations, has launched its first-ever vaccine trial for the Sudan strain of Ebola. The trial began just days after a nurse succumbed to the virus, with additional cases confirmed among his relatives. Researchers at Makerere University and the Uganda Virus Research Institute expedited the process, ensuring compliance with ethical and regulatory standards. The candidate vaccine, donated by IAVI and funded by international partners, aims to improve pandemic preparedness. Over 2,000 doses are available, though the manufacturer remains undisclosed. Uganda has a history of Ebola outbreaks, including a deadly 2000 epidemic. Contact tracing remains essential in containing the disease. This outbreak comes amid US funding freezes following the Trump administration’s withdrawal from the WHO. The region has also faced recent outbreaks of Marburg virus in Tanzania and Rwanda. Officials hope the vaccine will be a breakthrough in combating future Ebola epidemics.